Lupin's arm gets UK regulator nod for COPD treatmentGlobal pharma major Lupin Limited on Friday announced that its UK subsidiary, Lupin Healthcare (UK) Limited, has received approval from the...
Variant-adapted Covid vaccine wins first approval in BritainThe UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by U.S. drug company Moderna as a booster for adults. The ag...
UK drug regulatory approves COVID antiviral drug MolnupiravirThe risk factors include obesity, older age (>60 years), diabetes mellitus, or heart disease. MHRA recommended the use of Molnupiravir as s...
Biocon's arm gets GMP compliance certificate from UK's health regulator MHRA for Bengaluru facilityThe certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, wa...
UK regulator found total of 30 cases of blood clot events after AstraZeneca vaccine useMHRA, European Medicines Agency and the World Health Organization have reiterated that benefits of the vaccine in the prevention of COVID-1...
UK regulator to fast-track vaccine updates to combat new Covid variantsMHRA said this is because authorised COVID-19 vaccines that are modified in response to new variants will not need a brand new approval o...
Quest Life mulls appeal against MHRA marketing suspension of drugsFive products and three companies are impacted by the MHRA action. All the studies were conducted in the year 2013-14 and one study conduct...
Wockhardt shares up 3% as UK MHRA makes no critical observationsShares of drug firm Wockhardt today surged 3 per cent after the company said the UK health regulator MHRA has completed inspection of its p...
Wockhardt climbs 4% after MHRA completes plant inspectionThe stock jumped 3.65% to hit a high of Rs 1,597.15 on the exchange. Still, the stock is trading 20% lower from its all-time high of Rs 2,0...
India, UK health regulators sign MoU to boost public safetyTo increase collaboration in the area of medicines and medical devices, UK's MHRA today signed a MoU with its counterpart body in India.
Claris Lifesciences shares up 3.5 per cent on BSEStock of Claris Life ended the day 3.56 per cent higher at Rs 181.60 on the BSE. In intra-day, it gained 6.33 per cent to Rs 186.45.
Claris Lifesciences gets Medicines and Healthcare products Regulatory Agency's nod for new plant"This is the first regulatory inspection and compliance approval conducted by MHRA-UK in line with the EU GMP regulations for plant 2."
Another Wockhardt plant under MHRA scannerThis is the drug maker's second plant whose GMP certificate has been taken away by MHRA and the third to face regulatory heat this year.
UK regulator MHRA recalls 16 drugs made at Wockhardt's Waluj plantMHRA today said it has issued a precautionary recall for sixteen medicines made by Wockhardt at its Waluj unit due to manufacturing shortco...
UK regulator issues import alert on Wockhardt's Waluj plant in MaharashtraDrug firm Wockhardt today said UK Medicines and MHRA has imposed an import alert on Wockhardt's export-oriented Unit plant at Waluj in Maha...
- Claris receives MHRA approval for Ahmedabad unit
Claris Lifesciences Limited today announced that it has received approval for its plant at Ahmedabad from the MHRA of the United Kingdom.
- Bafna Pharma bags UK nod for Paracetamol, Loperamide
Bafna Pharmaceuticals on Thursday said it has received approval from the UK health regulator to produce popular drug Paracetamol and Lopera...